glycine has been researched along with Osteosarcoma in 9 studies
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteosarcoma is the major malignant primary bone cancer in children and adolescents, which is highly aggressive with frequent acquisition of chemoresistance phenotypes." | 5.46 | A novel mechanism of mTORC1-mediated serine/glycine metabolism in osteosarcoma development. ( Bi, ZG; Cao, Y; E, XQ; Ji, G; Liu, W; Wang, DW; Wu, L; Yang, L, 2017) |
| " It was revealed that microwaving to 48˚C combined with HSP90 and TGF‑β1 inhibitors significantly increased the apoptotic rate of VX2 cells." | 1.56 | Mild microwave ablation combined with HSP90 and TGF‑β1 inhibitors enhances the therapeutic effect on osteosarcoma. ( Chen, L; Cheng, S; Li, B; Lin, Z; Wang, M; Wang, W; Yao, M; Yin, Q; Zhang, Y, 2020) |
| "Co-treatment with bortezomib and either doxorubicin or carboplatin was more toxic to canine osteosarcoma cells than each agent alone." | 1.48 | Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma. ( Hawkins, CJ; Patatsos, K; Shekhar, TM, 2018) |
| "Osteosarcoma is the major malignant primary bone cancer in children and adolescents, which is highly aggressive with frequent acquisition of chemoresistance phenotypes." | 1.46 | A novel mechanism of mTORC1-mediated serine/glycine metabolism in osteosarcoma development. ( Bi, ZG; Cao, Y; E, XQ; Ji, G; Liu, W; Wang, DW; Wu, L; Yang, L, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Ishizaki, J | 1 |
| Nakano, C | 1 |
| Kitagawa, K | 1 |
| Suga, Y | 1 |
| Sai, Y | 1 |
| Nam, A | 1 |
| Kim, T | 1 |
| Li, Q | 1 |
| Rebhun, RB | 1 |
| Youn, HY | 1 |
| Seo, KW | 1 |
| Chen, L | 1 |
| Wang, M | 1 |
| Lin, Z | 1 |
| Yao, M | 1 |
| Wang, W | 1 |
| Cheng, S | 1 |
| Li, B | 1 |
| Zhang, Y | 1 |
| Yin, Q | 1 |
| Patatsos, K | 1 |
| Shekhar, TM | 1 |
| Hawkins, CJ | 1 |
| Wang, DW | 1 |
| Wu, L | 1 |
| Cao, Y | 1 |
| Yang, L | 1 |
| Liu, W | 1 |
| E, XQ | 1 |
| Ji, G | 1 |
| Bi, ZG | 1 |
| Liu, R | 1 |
| Fu, C | 1 |
| Sun, J | 1 |
| Wang, X | 2 |
| Geng, S | 1 |
| Zou, J | 1 |
| Bi, Z | 1 |
| Yang, C | 1 |
| Gorska-Ponikowska, M | 1 |
| Perricone, U | 1 |
| Kuban-Jankowska, A | 1 |
| Lo Bosco, G | 1 |
| Barone, G | 1 |
| Marques, J | 1 |
| Santos, TM | 1 |
| Marques, MP | 1 |
| Braga, SS | 1 |
| Mazzaferro, EM | 1 |
| Hackett, TB | 1 |
| Stein, TP | 1 |
| Ogilvie, GK | 1 |
| Wingfield, WE | 1 |
| Walton, J | 1 |
| Turner, AS | 1 |
| Fettman, MJ | 1 |
9 other studies available for glycine and Osteosarcoma
| Article | Year |
|---|---|
A Previously Unknown Drug-Drug Interaction Is Suspected in Delayed Elimination of Plasma Methotrexate in High-Dose Methotrexate Therapy.
Topics: Cysteine; Drug Combinations; Drug Interactions; Drug Monitoring; Female; Glycine; Glycyrrhetinic Aci | 2020 |
Melarsomine suppresses canine osteosarcoma cell survival via inhibition of Hedgehog-GLI signaling.
Topics: Animals; Apoptosis; Arsenicals; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Cell Survival; | 2019 |
Mild microwave ablation combined with HSP90 and TGF‑β1 inhibitors enhances the therapeutic effect on osteosarcoma.
Topics: Animals; Apoptosis; Benzamides; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Disease Models, Ani | 2020 |
Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Bone Neoplasms; Boron Compounds; Boronic Acids; B | 2018 |
A novel mechanism of mTORC1-mediated serine/glycine metabolism in osteosarcoma development.
Topics: Apoptosis; Carbon; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Glycine; Humans; Mechanisti | 2017 |
A New Perspective for Osteosarcoma Therapy: Proteasome Inhibition by MLN9708/2238 Successfully Induces Apoptosis and Cell Cycle Arrest and Attenuates the Invasion Ability of Osteosarcoma Cells in Vitro.
Topics: Apoptosis; bcl-2-Associated X Protein; Boron Compounds; Cell Cycle Checkpoints; Cell Line, Tumor; Ce | 2017 |
2-methoxyestradiol impacts on amino acids-mediated metabolic reprogramming in osteosarcoma cells by its interaction with NMDA receptor.
Topics: 2-Methoxyestradiol; Antineoplastic Agents; Binding Sites; Bone Neoplasms; Breast Neoplasms; Cell Mov | 2017 |
A glycine ruthenium trithiacyclononane complex and its molecular encapsulation using cyclodextrins.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Coo | 2009 |
Metabolic alterations in dogs with osteosarcoma.
Topics: Absorptiometry, Photon; Animals; Bone Neoplasms; Calorimetry, Indirect; Dog Diseases; Dogs; Energy M | 2001 |